LATEST NEWS

Recent Articles from TheStreet

Boeing 737 Max Lead

Boeing Pilot Reportedly Likely to Face Charges Over 737 Max

The Justice Department reportedly intends to file criminal charges against a Boeing pilot who it believes misled the FAA.

Take-Two Interactive Lead

Premarket Movers Friday - Take-Two, Lucid, Invesco, AbCellera

Stocks moving in premarket trading Friday include Take-Two Interactive, Invesco, Lucid, Manchester United and AbCellera.

Zoom Five9 Lead

Zoom Stock Gains On Report ISS Recommends Five9 Shareholders Reject Takeover Bid

CNBC's David Faber said Friday that ISS will recommend that Five9 shareholders reject Zoom's all-stock takeover bid.

United Airlines Reports Cyber Breach, Chinese Group Suspected

United Airlines Briefly Grounds US, Canada Flights After System Failure

United Airlines grounded all north American flights for around 45 minutes Friday following 'technical issues' and reports of a system failure.

NYSE Lead

Dow Futures Slip Lower Into 'Quadruple Witching Hour', China Woes Clip Global Stocks

China's slowing growth, corporate crackdowns and system risk concerns have global stocks on the back foot Friday heading into Wall Street's 'quadruple witching hour'.

US Steel Surges After Smaller-Than-Expected Q3 Loss on Solid Flat Rolled Demand

U.S. Steel Stock Slides After Q3 Profit Update, Big New Mill Plans

“We expect the third quarter to be a quarter of records for U. S. Steel.," said CEO David Burritt. ""Our best days are ahead.”

Wall Street Lead

Stocks Edge Lower, FDA Debates Boosters ,China Evergrande Wobbles - 5 Things You Must Know

Stock futures lower heading into 'quadruple witching hour'; FDA panel debates COVID boosters; U.S. Steel updates on profits and China Evergrande's debt woes have investors asking if it's 'too big to fail'.

Hamburgers

Grill Company Traeger's Chart Shows a Possible Turn

Real Money's Tim Cook has spotted a key pattern in the newly public company's trading.

Coronavirus: Constantly Surprising Virus Found To Be Heat Tolerant, Self-healing And Very Resilient In Lab Tests

AbCellera, Kymera and Diamondback Move in After-Hours

Drug maker AbCellera wins emergency use authorization for COVID treatment.